Kiniksa Pharmaceuticals, Ltd. (KNSA) Ownership

$19.31

north_east
$0.66 (3.54%)
Day's range
$18.4
Day's range
$19.34

Kiniksa Pharmaceuticals, Ltd. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/07/2025 3.57 M $70.65 M   -6.43% 5.00%
BRAIDWELL LP 02/14/2025 3.45 M $68.29 M   19.28% 4.83%
BAKER BROS. ADVISORS LP 02/14/2025 2.82 M $55.75 M   0.00% 3.95%
RUBRIC CAPITAL MANAGEMENT LP 02/14/2025 2.62 M $51.81 M   8.27% 3.67%
FAIRMOUNT FUNDS MANAGEMENT LLC 02/14/2025 2.19 M $43.40 M   -31.53% 3.07%
HHLR ADVISORS, LTD. 02/14/2025 1.58 M $31.30 M   0.00% 2.22%
MORGAN STANLEY 02/14/2025 1.49 M $29.43 M   45.08% 2.08%
PICTET ASSET MANAGEMENT HOLDING SA 02/12/2025 1.13 M $22.43 M   -6.11% 1.59%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 795,612 $15.74 M   7.33% 1.11%
MILLENNIUM MANAGEMENT LLC 02/14/2025 779,672 $15.42 M   50.95% 1.09%
PARKMAN HEALTHCARE PARTNERS LLC 02/14/2025 765,453 $15.14 M   1.35% 1.07%
STATE STREET CORP 02/14/2025 729,579 $14.43 M   3.53% 1.02%
FMR LLC 02/13/2025 705,341 $13.95 M   1.22% 0.99%
RICE HALL JAMES & ASSOCIATES, LLC 01/31/2025 642,752 $12.71 M   -1.06% 0.90%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 628,609 $12.43 M   0.00% 0.88%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/14/2025 613,550 $12.14 M   -16.06% 0.86%
ARROWMARK COLORADO HOLDINGS LLC 02/14/2025 521,889 $10.32 M   -1.77% 0.73%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 492,630 $9.74 M   2.00% 0.69%
GRANAHAN INVESTMENT MANAGEMENT, LLC 02/14/2025 463,110 $9.16 M   -8.72% 0.65%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 420,130 $8.31 M   8.18% 0.59%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 382,621 $7.56 M   260.22% 0.54%
D. E. SHAW & CO., INC. 02/14/2025 320,007 $6.33 M   -0.31% 0.45%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 306,946 $6.07 M   -5.28% 0.43%
CITADEL ADVISORS LLC 02/14/2025 304,576 $6.02 M   53.51% 0.43%
NORTHERN TRUST CORP 02/14/2025 283,599 $5.61 M   11.13% 0.40%
PEREGRINE CAPITAL MANAGEMENT LLC 01/31/2025 244,043 $4.83 M   1.82% 0.34%
OBERWEIS ASSET MANAGEMENT INC/ 02/14/2025 237,200 $4.69 M   18.01% 0.33%
HUDSON BAY CAPITAL MANAGEMENT LP 02/14/2025 225,000 $4.45 M   150.00% 0.32%
BANK OF AMERICA CORP /DE/ 02/14/2025 215,772 $4.27 M   2.20% 0.30%
RAYMOND JAMES FINANCIAL INC 02/13/2025 199,953 $3.96 M   100.00% 0.28%
HENNION & WALSH ASSET MANAGEMENT, INC. 01/15/2025 199,525 $3.95 M   1.88% 0.28%
NORDEA INVESTMENT MANAGEMENT AB 01/06/2025 194,883 $3.82 M   4.42% 0.27%
ESSEX INVESTMENT MANAGEMENT CO LLC 02/07/2025 173,799 $3.44 M   -13.32% 0.24%
ADAR1 CAPITAL MANAGEMENT, LLC 02/13/2025 166,406 $3.29 M   -61.89% 0.23%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/14/2025 140,878 $2.79 M   -25.85% 0.20%
ALGERT GLOBAL LLC 02/14/2025 135,814 $2.69 M   48.99% 0.19%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/12/2025 127,161 $2.52 M   965.18% 0.18%
LINDEN THOMAS ADVISORY SERVICES, LLC 01/21/2025 117,604 $2.33 M   -0.09% 0.16%
STATE OF WISCONSIN INVESTMENT BOARD 02/14/2025 112,519 $2.23 M   -1.95% 0.16%
JEFFERIES FINANCIAL GROUP INC. 02/27/2025 112,400 $2.22 M   39.45% 0.16%
UBS OCONNOR LLC 02/14/2025 99,632 $1.97 M   32.54% 0.14%
HARBOR CAPITAL ADVISORS, INC. 01/10/2025 98,093 $1.94 M   0.56% 0.14%
PRUDENTIAL FINANCIAL INC 02/11/2025 91,920 $1.82 M   -22.57% 0.13%
GLOBEFLEX CAPITAL L P 02/10/2025 88,596 $1.75 M   217.09% 0.12%
MARSHALL WACE, LLP 02/13/2025 86,762 $1.72 M   -4.21% 0.12%
TREXQUANT INVESTMENT LP 02/12/2025 80,842 $1.60 M   -47.91% 0.11%
HIGHVISTA STRATEGIES LLC 02/14/2025 74,639 $1.48 M   0.00% 0.10%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 69,813 $1.38 M   46.31% 0.10%
FRANKLIN RESOURCES INC 02/12/2025 67,320 $1.33 M   -0.32% 0.09%
PDT PARTNERS, LLC 02/14/2025 64,917 $1.28 M   74.31% 0.09%

Kiniksa Pharmaceuticals, Ltd. institutional Ownership - FAQ's

During the previous two years, 164 institutional investors and hedge funds held shares of Kiniksa Pharmaceuticals, Ltd.. The most heavily invested institutionals were:

BlackRock, Inc.: 3.57 M

BRAIDWELL LP: 3.45 M

BAKER BROS. ADVISORS LP: 2.82 M

Rubric Capital Management LP: 2.62 M

Fairmount Funds Management LLC: 2.19 M

HHLR ADVISORS, LTD.: 1.58 M

54.61% of Kiniksa Pharmaceuticals, Ltd. stock is owned by institutional investors.

Institutional investors have bought a total of 42.88 M shares in the last 24 months. This purchase volume represents approximately $828.00 M in transactions.